Results 201 to 210 of about 363,359 (243)

Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective We aimed to assess vedolizumab and ustekinumab efficacy and safety in patients with very‐early onset inflammatory bowel disease (VEO‐IBD). Methods A retrospective study involving 29 European and North American sites affiliated with the IBD Porto Group of European Society for Paediatric Gastroenterology Hepatology and Nutrition ...
Luca Scarallo   +45 more
wiley   +1 more source

Human immunodeficiency virus infection mimicking very early onset inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Very early onset inflammatory bowel disease (VEO‐IBD), defined as diagnosis before 6 years of age, is often associated with immune dysregulation and monogenic etiologies; however, infectious mimics may be overlooked in low‐prevalence regions. We report a 4‐year‐old male with poor weight gain, intermittent diarrhea, elevated fecal calprotectin,
Rasha Abi Radi Abou Jaoudeh   +2 more
wiley   +1 more source

Severe constipation‐associated postprandial abdominal pain in a pregnant native‐liver biliary atresia survivor after Kasai portoenterostomy: A case report

open access: yesJPGN Reports, EarlyView.
ABSTRACT An 18‐year‐old woman with congenital biliary atresia status post Kasai portoenterostomy and magnetic resonance imaging‐reported chronic liver disease presented at 32 weeks’ gestation with 6 weeks of worsening postprandial epigastric/right upper quadrant pain, nausea, and poor oral intake.
Akram Alnounou   +6 more
wiley   +1 more source

Multi‐segment intussusception in infant with suspected celiac crisis: A case report

open access: yesJPGN Reports, EarlyView.
Abstract Celiac crisis (CC) is a rare, life‐threatening manifestation of often undiagnosed or inadequately treated celiac disease (CeD). In infants with nonclassical presentations of CeD, timely diagnosis can be challenging but critical to reducing end‐organ damage and serious complications, such as CC.
Shambhawi Thakur   +4 more
wiley   +1 more source

Beyond the gut: Non‐specific interstitial pneumonia in pediatric ulcerative colitis—A rare extra‐intestinal manifestation

open access: yesJPGN Reports, EarlyView.
Abstract Inflammatory bowel disease (IBD) is a chronic inflammatory disorder often presenting with extra‐intestinal manifestations (EIMs) involving the skin, joints and eyes. However, pulmonary manifestation, such as interstitial lung disease (ILD), is a rare complication, particularly in the pediatric population. We report a case of a 10‐year‐old boy,
Harshit Vachher   +5 more
wiley   +1 more source

Vedolizumab use for severe chronic enterocolitis in a child with Hoyeraal–Hreidarsson syndrome: A case report

open access: yesJPGN Reports, EarlyView.
Abstract We report a patient with Hoyeraal–Hreidarsson syndrome (HHS), a telomere biology disorder, who developed severe chronic enterocolitis with inflammatory bowel disease‐like features. Vedolizumab led to improvement in stool frequency, reduced fecal calprotectin, and clinical remission without infectious complications.
Yasutaka Chiba   +6 more
wiley   +1 more source

Candidemia in patients with intestinal failure: Diagnostic utility of fungal blood cultures

open access: yesJPGN Reports, EarlyView.
Abstract Objective Pediatric patients with intestinal failure (IF) receiving parenteral nutrition are at increased risk for candidemia. Evaluation of central line–associated bloodstream infection often includes aerobic, anaerobic, and fungal blood cultures, but the diagnostic yield of dedicated fungal cultures is uncertain.
Sona Sehgal   +5 more
wiley   +1 more source

Chemotherapy After Resection of Pancreatic Ductal Adenocarcinoma: Impact of Different Regimens in a Real‐World Population

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Introduction The PRODIGE 24/CCTG PA.6‐ trial has shown an overall survival (OS) up to 55 months in patients treated with (modified) 5‐fluorouracil, leucovorin, irinotecan and oxaliplatin ((m)FOLFIRINOX) chemotherapy after resection of pancreatic ductal adenocarcinoma (PDAC). The applicability of these results to a real‐world patient population
N. C. Biesma   +7 more
wiley   +1 more source

Ewing's Sarcoma in Adults: A Predictive Nomogram and Survival Analysis of a Cohort of 937 Patients

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Ewing sarcoma is a rare malignancy of bone and soft tissue that most commonly affects children, adolescents, and young adults. Although multimodal treatment has improved survival in localised disease, outcomes remain poorer in adults, particularly in those with metastatic disease, larger tumours, or anatomically complex primary ...
Jonathan Gibson   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy